Paul Tudor Jones Exact Sciences Corp Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Exact Sciences Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 10,530 shares of EXAS stock, worth $500,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,530
Previous 3,800
177.11%
Holding current value
$500,596
Previous $213,000
113.62%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding EXAS
# of Institutions
638Shares Held
156MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$848 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$838 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$594 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$574 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$314 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.41B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...